SLEEP NUMBER CORP (SNBR)

US83125X1037 - Common Stock

13.63  -0.55 (-3.88%)

After market: 13.63 0 (0%)

Fundamental Rating

2

SNBR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 126 industry peers in the Specialty Retail industry. There are concerns on the financial health of SNBR while its profitability can be described as average. SNBR does not seem to be growing, but still is valued expensively.



4

1. Profitability

1.1 Basic Checks

SNBR had negative earnings in the past year.
SNBR had a negative operating cash flow in the past year.
SNBR had positive earnings in 4 of the past 5 years.
SNBR had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

SNBR's Return On Assets of -1.60% is in line compared to the rest of the industry. SNBR outperforms 45.24% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.22%, SNBR is in line with its industry, outperforming 54.76% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SNBR is above the industry average of 13.99%.
The last Return On Invested Capital (5.22%) for SNBR is well below the 3 year average (17.46%), which needs to be investigated, but indicates that SNBR had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.6%
ROE N/A
ROIC 5.22%
ROA(3y)6.31%
ROA(5y)9.3%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.46%
ROIC(5y)21.4%

1.3 Margins

With a Operating Margin value of 2.05%, SNBR perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
SNBR's Operating Margin has declined in the last couple of years.
SNBR has a Gross Margin of 57.67%. This is amongst the best in the industry. SNBR outperforms 89.68% of its industry peers.
In the last couple of years the Gross Margin of SNBR has remained more or less at the same level.
Industry RankSector Rank
OM 2.05%
PM (TTM) N/A
GM 57.67%
OM growth 3Y-40.97%
OM growth 5Y-19.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.52%
GM growth 5Y-0.98%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNBR is creating value.
SNBR has more shares outstanding than it did 1 year ago.
SNBR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for SNBR is higher compared to a year ago.

2.2 Solvency

SNBR has an Altman-Z score of 0.66. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.66, SNBR is not doing good in the industry: 80.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.66
ROIC/WACC0.56
WACC9.31%

2.3 Liquidity

A Current Ratio of 0.22 indicates that SNBR may have some problems paying its short term obligations.
The Current ratio of SNBR (0.22) is worse than 99.21% of its industry peers.
A Quick Ratio of 0.10 indicates that SNBR may have some problems paying its short term obligations.
SNBR has a worse Quick ratio (0.10) than 97.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.1

3

3. Growth

3.1 Past

SNBR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -142.24%.
SNBR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.73%.
Measured over the past years, SNBR shows a small growth in Revenue. The Revenue has been growing by 4.27% on average per year.
EPS 1Y (TTM)-142.24%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-366.67%
Revenue 1Y (TTM)-10.73%
Revenue growth 3Y0.55%
Revenue growth 5Y4.27%
Revenue growth Q2Q-13.66%

3.2 Future

Based on estimates for the next years, SNBR will show a very strong growth in Earnings Per Share. The EPS will grow by 45.32% on average per year.
The Revenue is expected to grow by 0.70% on average over the next years.
EPS Next Y72.7%
EPS Next 2Y79.3%
EPS Next 3Y58.28%
EPS Next 5Y45.32%
Revenue Next Year-3.91%
Revenue Next 2Y-0.5%
Revenue Next 3Y1.05%
Revenue Next 5Y0.7%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SNBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNBR is valued cheaply inside the industry as 97.62% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.79

4.3 Compensation for Growth

SNBR's earnings are expected to grow with 58.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.3%
EPS Next 3Y58.28%

0

5. Dividend

5.1 Amount

No dividends for SNBR!.
Industry RankSector Rank
Dividend Yield N/A

SLEEP NUMBER CORP

NASDAQ:SNBR (4/29/2024, 4:20:02 PM)

After market: 13.63 0 (0%)

13.63

-0.55 (-3.88%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap304.36M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.6%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 2.05%
PM (TTM) N/A
GM 57.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.22
Quick Ratio 0.1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-142.24%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y72.7%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-10.73%
Revenue growth 3Y0.55%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y